Several mechanisms of IRRs induced by rituximab have been reported: immunoglobulin E (IgE)-mediated hypersensitivity, anaphylactoid reaction (IgE-independent allergic reaction), and cytokine release syndrome (CRS) [18]. Here, IGHE is linked to congenital rubella syndrome.